Illumina, Inc. (NASDAQ:ILMN) is expected to report third quarter earnings results, after market close, on Thursday 29th October 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.77 per share from revenue of $ 715.91 million.
Looking ahead, the full year income are expected at $ 4.51 per share on the revenues of $ 3093.96 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 3,862.00 million ~ $ 3,933.00 million, where as bottomline are predicted in a range of $ 6.80 ~ $ 7.00 per share
Click Here For More Historical Outlooks Of Illumina, Inc.
Previous Quarter Performance
Illumina, Inc. unfold income for the second quarter of $ 0.62 per share, from the revenue of $ 633.00 million. The quarterly earnings down 54.07 percent while revenues fell 24.46 percent compared with the same quarter last year.
Wall street analysts are predicting, ILMN to report 2Q20 income of $ 0.67 per share from revenue of $ 679.56 million. The bottom line results missed street analysts by $ 0.05 or 7.46 percent, at the same time, top line results fell short of analysts by $ 46.56 million or 6.85 percent.
Stock Performance
Shares of Illumina, Inc. traded low $ -12.05 or -3.75 percent on Wednesday, reaching $ 309.69 with volume of 1.25 million shares. Illumina, Inc. has traded high as $ 320.00 and has cracked $ 309.66 on the downward trend
According to the previous trading day, closing price of $ 309.69, representing a 63.50 % increase from the 52 week low of $ 196.78 and a 20.4 % decrease over the 52 week high of $ 404.20.
The company has a market capital of $ 45.33 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Recent Analyst recommendations
- On 13th October 2020, downgraded by Guggenheim to Neutral from Buy rating.
- On 22nd September 2020, maintained by Robert W. Baird at Neutral rating, with $ 281.00 target price.
- On 22nd September 2020, maintained by Canaccord Genuity at Hold rating, with $ 300.00 target price.
- On 22nd September 2020, maintained by SVB Leerink at Outperform rating, with $ 315.00 target price.
- On 22nd September 2020, downgraded by Stifel Nicolaus to Hold from Buy rating, with $ 280.00 target price.
Conference Call
Illumina, Inc. will be hosting a conference call at 5:00 PM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.illumina.com
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs.
